CN101810819A - Medicaments for treating and preventing pancreatic diseases - Google Patents

Medicaments for treating and preventing pancreatic diseases Download PDF

Info

Publication number
CN101810819A
CN101810819A CN201010160399A CN201010160399A CN101810819A CN 101810819 A CN101810819 A CN 101810819A CN 201010160399 A CN201010160399 A CN 201010160399A CN 201010160399 A CN201010160399 A CN 201010160399A CN 101810819 A CN101810819 A CN 101810819A
Authority
CN
China
Prior art keywords
radix
rhizoma
medicaments
treating
pancreatic diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201010160399A
Other languages
Chinese (zh)
Inventor
黄泳葛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanning Pindi Biological Engineering Co., Ltd.
Original Assignee
黄泳葛
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 黄泳葛 filed Critical 黄泳葛
Priority to CN201010160399A priority Critical patent/CN101810819A/en
Publication of CN101810819A publication Critical patent/CN101810819A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a group of medicaments for treating and preventing pancreatic diseases. The medicaments are prepared from twenty nine kinds of Chinese medicaments comprising mongolian snakegourd root, bupleurum, costustoot, rhizoma corydalis, nutgrass galingale rhizome and the like. The medicaments can course the liver and disinhibit the gallbladder, have obvious effect of curing pancreatitis, can achieve the effect of both treating and nourishing, treat both symptoms and root causes, and have the advantages of fast effects, short treating time, no toxic and side effects, no relapse after curing, capability of curing gastritis, enteritis, qi depression inhibition, pleuroperitoneal distention and fullness, nausea and vomiting, transforming stagnation and bowel freeing, and constipation and indigestion. Moreover, when normally administrated, the medicaments have good effect of preventing the pancreatic diseases.

Description

One group of medicine that pancreatic diseases is had treatment and preventive effect
Technical field: what the present invention relates to is one group of medicine that pancreatic diseases is had treatment and preventive effect.
Background technology: eating and drinking without temperance will get pancreatitis, and as long as modern medicine has to such an extent that treat untimely entail dangers to life based on antiinflammatory, and the medicine of this respect also has, and all is treatment afterwards.
Summary of the invention: the objective of the invention is to prevent the generation of pancreatic diseases, and can do the early treatment, be achieved in that specifically in mass percent be 2-20% pollen, 2-20% Radix Bupleuri, the 2-20% Rhizoma Coptidis, the 2-20% Radix Scutellariae, the 2-20% Herba Hedyotidis Diffusae, 2-20% Semen Vignae Cylindricae bandit, the 2-20% Pericarpium Citri Reticulatae Viride, the 2-15% Fructus Foeniculi, the 2-20% Rhizoma Alismatis, 2-15% cattle lacquer, the 2-20% Radix Notoginseng, the 2-15% Herba Scutellariae Barbatae, the 2-15% Radix Aucklandiae, the 2-20% Radix Paeoniae Alba, the 2-20% Radix Et Rhizoma Rhei, the 2-20% Natrii Sulfas, the 2-15% Fructus Aurantii Immaturus, the 2-15% Rhizoma Pinelliae, the 2-20% Rhizoma Corydalis, the 2-20% Rhizoma Corydalis, the 2-20% Radix Ginseng, the 2-20% Rhizoma Cyperi, the 2-15% Rhizoma Chuanxiong, the 2-15% Flos Carthami, the 2-20% Radix Salviae Miltiorrhizae, the 2-20% Cortex Meliae, the 2-20% Radix Angelicae Sinensis, the 2-20% Oletum Trogopterori, in 29 kinds of Chinese medicines of 2-20% Radix Glycyrrhizae, pollen, Radix Ginseng and Radix Notoginseng be micronizing separately, 26 kinds of remaining Chinese medicines are cleaned, airing, mix, pulverize, the decocting in water alcohol extraction, concentrate the sulfur extractum that obtains suiting, add through fine Radix Notoginseng and Radix Ginseng, pollen, add the excipient substance that meets medicinal requirements and ratio, make different buccal tablets as required, plain sheet, powder, capsule, pill, granule, pro ore.
The specific embodiment: the present invention is described in detail below in conjunction with embodiment
Embodiment one: with mass percent is 2% pollen, 2% Radix Bupleuri, 4% Rhizoma Coptidis, 4% Radix Scutellariae, 4% Herba Hedyotidis Diffusae, 4% Semen Vignae Cylindricae bandit, 4% Pericarpium Citri Reticulatae Viride, 4% Fructus Foeniculi, 4% Rhizoma Alismatis, 4% N of lacquer, 4% Radix Notoginseng, 4% Herba Scutellariae Barbatae, 4% Radix Aucklandiae, 4% Radix Paeoniae Alba, 4% Radix Et Rhizoma Rhei, 4% Natrii Sulfas, 4% Fructus Aurantii Immaturus, 4% Rhizoma Pinelliae, 4% Rhizoma Corydalis, 4% Rhizoma Corydalis, 4% Radix Ginseng, 4% Rhizoma Cyperi, 4% Rhizoma Chuanxiong, 2% Flos Carthami, 2% Radix Salviae Miltiorrhizae, 2% Cortex Meliae, 2% Radix Angelicae Sinensis, 2% Oletum Trogopterori, in 28 kinds of Chinese medicines of 2% Radix Glycyrrhizae, Radix Ginseng and Radix Notoginseng be micronizing separately, 26 kinds of remaining Chinese medicines are cleaned, airing, mix, pulverize, the decocting in water alcohol extraction, concentrate the sulfur extractum that obtains suiting, add through fine Radix Notoginseng and Radix Ginseng, add the excipient substance that meets medicinal requirements and ratio, make buccal tablet as required, for oral use for the patient.
Embodiment two: with mass percent is 3% pollen, 2% Radix Bupleuri, 5% Rhizoma Coptidis, 5% Radix Scutellariae, 5% Herba Hedyotidis Diffusae, 3% Semen Vignae Cylindricae bandit, 3% Pericarpium Citri Reticulatae Viride, 3% Fructus Foeniculi, 3% Rhizoma Alismatis, 4% N of lacquer, 4% Radix Notoginseng, 4% Herba Scutellariae Barbatae, 4% Radix Aucklandiae, 4% Radix Paeoniae Alba, 5% Radix Et Rhizoma Rhei, 5% Natrii Sulfas, 5% Fructus Aurantii Immaturus, 5% Rhizoma Pinelliae, 3% Rhizoma Corydalis, 3% Rhizoma Corydalis, 3% Radix Ginseng, 3% Rhizoma Cyperi, 4% Rhizoma Chuanxiong, 2% Flos Carthami, 2% Radix Salviae Miltiorrhizae, 2% Cortex Meliae, 2% Radix Angelicae Sinensis, 2% Oletum Trogopterori, in 29 kinds of Chinese medicines of 2% Radix Glycyrrhizae, pollen, Radix Ginseng and Radix Notoginseng be micronizing separately, 26 kinds of remaining Chinese medicines are cleaned, airing, mix, pulverize, the decocting in water alcohol extraction, concentrate the sulfur extractum that obtains suiting, add through fine Radix Notoginseng and Radix Ginseng, pollen, add the excipient substance that meets medicinal requirements and ratio, make plain sheet as required, for oral use for the patient.
Embodiment three: with mass percent is 2% pollen, 2% Radix Bupleuri, 2% Rhizoma Coptidis, 3% Radix Scutellariae, 3% Herba Hedyotidis Diffusae, 5% Semen Vignae Cylindricae bandit, 5% Pericarpium Citri Reticulatae Viride, 5% Fructus Foeniculi, 5% Rhizoma Alismatis, 4% N of lacquer, 4% Radix Notoginseng, 4% Herba Scutellariae Barbatae, 4% Radix Aucklandiae, 4% Radix Paeoniae Alba, 3% Radix Et Rhizoma Rhei, 3% Natrii Sulfas, 3% Fructus Aurantii Immaturus, 3% Rhizoma Pinelliae, 5% Rhizoma Corydalis, 5% Rhizoma Corydalis, 5% Radix Ginseng, 5% Rhizoma Cyperi, 2% Rhizoma Chuanxiong, 4% Flos Carthami, 2% Radix Salviae Miltiorrhizae, 2% Cortex Meliae, 2% Radix Angelicae Sinensis, 2% Oletum Trogopterori, in 29 kinds of Chinese medicines of 2% Radix Glycyrrhizae, pollen, Radix Ginseng and Radix Notoginseng be micronizing separately, 26 kinds of remaining Chinese medicines are cleaned, airing, mix, pulverize, the decocting in water alcohol extraction, concentrate the sulfur extractum that obtains suiting, add through fine Radix Notoginseng and Radix Ginseng, pollen, add the excipient substance that meets medicinal requirements and ratio, make capsule as required, for oral use for the patient.

Claims (1)

  1. FF. one group has the treatment and the medicine of preventive effect to pancreatic diseases, it is characterized in that the mass percent of medicine composition is: 2-20% pollen, 2-20% Radix Bupleuri, the 2-20% Rhizoma Coptidis, the 2-20% Radix Scutellariae, the 2-20% Herba Hedyotidis Diffusae, 2-20% Semen Vignae Cylindricae bandit, the 2-20% Pericarpium Citri Reticulatae Viride, the 2-15% Fructus Foeniculi, the 2-20% Rhizoma Alismatis, 2-15% cattle lacquer, the 2-20% Radix Notoginseng, the 2-15% Herba Scutellariae Barbatae, the 2-15% Radix Aucklandiae, the 2-20% Radix Paeoniae Alba, the 2-20% Radix Et Rhizoma Rhei, the 2-20% Natrii Sulfas, the 2-15% Fructus Aurantii Immaturus, the 2-15% Rhizoma Pinelliae, the 2-20% Rhizoma Corydalis, the 2-20% Rhizoma Corydalis, the 2-20% Radix Ginseng, the 2-20% Rhizoma Cyperi, the 2-15% Rhizoma Chuanxiong, the 2-15% Flos Carthami, the 2-20% Radix Salviae Miltiorrhizae, the 2-20% Cortex Meliae, the 2-20% Radix Angelicae Sinensis, the 2-20% Oletum Trogopterori, the 2-20% Radix Glycyrrhizae.
CN201010160399A 2010-04-30 2010-04-30 Medicaments for treating and preventing pancreatic diseases Pending CN101810819A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201010160399A CN101810819A (en) 2010-04-30 2010-04-30 Medicaments for treating and preventing pancreatic diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201010160399A CN101810819A (en) 2010-04-30 2010-04-30 Medicaments for treating and preventing pancreatic diseases

Publications (1)

Publication Number Publication Date
CN101810819A true CN101810819A (en) 2010-08-25

Family

ID=42618281

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201010160399A Pending CN101810819A (en) 2010-04-30 2010-04-30 Medicaments for treating and preventing pancreatic diseases

Country Status (1)

Country Link
CN (1) CN101810819A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103893597A (en) * 2014-03-30 2014-07-02 郭洪娜 Chinese medicinal preparation for treating chronic pancreatitis with wetness-heat of liver and gallbladder syndrome
CN103989780A (en) * 2014-05-31 2014-08-20 全椒县尹氏油脂有限公司 Traditional Chinese medicine for treating chronic pancreatitis
CN104352851A (en) * 2014-10-28 2015-02-18 匡玉华 Chinese medicinal honeyed pills for preventing and treating pancreatitis and preparation method for Chinese medicinal honeyed pills
CN104739961A (en) * 2015-04-06 2015-07-01 刘爱国 Traditional Chinese medicine for treatment of acute pancreatitis and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101172151A (en) * 2006-10-31 2008-05-07 王文喜 Traditional Chinese medicine for treating pancreatitis and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101172151A (en) * 2006-10-31 2008-05-07 王文喜 Traditional Chinese medicine for treating pancreatitis and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
吴学勇: "胰腺癌中医药治疗进展", 《中医研究》, vol. 14, no. 1, 28 February 2001 (2001-02-28), pages 35 - 37 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103893597A (en) * 2014-03-30 2014-07-02 郭洪娜 Chinese medicinal preparation for treating chronic pancreatitis with wetness-heat of liver and gallbladder syndrome
CN103989780A (en) * 2014-05-31 2014-08-20 全椒县尹氏油脂有限公司 Traditional Chinese medicine for treating chronic pancreatitis
CN104352851A (en) * 2014-10-28 2015-02-18 匡玉华 Chinese medicinal honeyed pills for preventing and treating pancreatitis and preparation method for Chinese medicinal honeyed pills
CN104739961A (en) * 2015-04-06 2015-07-01 刘爱国 Traditional Chinese medicine for treatment of acute pancreatitis and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101829280B (en) Chinese medicinal herb formulation for preventing aypnia and promoting sweet sleep
CN102961497A (en) Chinese herbal compound prescription used for treating chronic diarrhea
CN101810819A (en) Medicaments for treating and preventing pancreatic diseases
CN101745092A (en) Traditional Chinese medicine for treating infantile diarrhea
CN102309601A (en) Traditional Chinese medicine (TCM) prescription for treating chloasma
CN1159037C (en) Medicine for treating apoplexy
CN101190318A (en) Traditional Chinese medicine for treating I-type and II-type diabetes
CN102688415A (en) Traditional Chinese medicine composition for treating anemia and preparation method thereof
CN101757206A (en) Chinese medicine preparation for treating chronic colitis
CN103446555A (en) Chinese medicinal composition for treating cholecystitis
CN1240415C (en) Tablets against allergic purpura
CN102309600A (en) Traditional Chinese medicine prescription for treating acne rosacea
CN101732423A (en) Chinese medicinal pills for treating hepatosplenomegaly
CN102397371A (en) Medicament for treating stomach illness
CN102309584A (en) Traditional Chinese medicine (TCM) prescription for treating postpartum hypogalactia
CN102048930A (en) Formula of traditional Chinese medicine for treating chronic gastritis
CN101757196A (en) Traditional Chinese medicine pills for treating blood and qi deficiency and spleen and stomach weakness
CN106031786A (en) Radix scutellariae and radix curcumae pills
CN102370867A (en) Chinese medicinal prescription for treating postnatal constipation
CN101804115A (en) Stubborn dermatitis rehabilitation pill
CN103070969A (en) Chinese medicinal composition for reducing blood fat and preparation method thereof
CN101822727A (en) Prescription for treating As-permia and Oligosperm
CN102309648A (en) Traditional Chinese medicine prescription for treating postpartum retention of lochia
CN101062181A (en) Angelica sinensis decoction for treating arthralgia
CN102078429A (en) Chinese traditional medicine powder for treating constipation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: NANNING PINDI BIOENGINEERING CO., LTD.

Free format text: FORMER OWNER: HUANG YONGGE

Effective date: 20120621

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 530215 NANNING, GUANGXI ZHUANG AUTONOMOUS REGION TO: 530007 NANNING, GUANGXI ZHUANG AUTONOMOUS REGION

TA01 Transfer of patent application right

Effective date of registration: 20120621

Address after: 530007, room 312, third floor, Nanning science and technology enterprise incubation building, 25 East High Tech Avenue, the Guangxi Zhuang Autonomous Region, Nanning

Applicant after: Nanning Pindi Biological Engineering Co., Ltd.

Address before: 530215, the Guangxi Zhuang Autonomous Region, Xingning Nanning District five town sand Ping Village, that is still No. 18 slope

Applicant before: Huang Yongge

DD01 Delivery of document by public notice

Addressee: Nanning Pindi Biological Engineering Co., Ltd.

Document name: Notification of an Office Action

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20100825